Keyphrases
Autonomic Imbalance
16%
Autonomic Nervous System
33%
Brain Regions
16%
Central Pain Modulation
16%
Chronic Neuropathic Pain
100%
Chronic Pain
50%
Clinical Trial Registry
16%
Conditioned Pain Modulation
100%
Connectivity Change
16%
Dorsolateral Prefrontal Cortex (DLPFC)
16%
Double-blind Placebo-controlled Trial
100%
Dysregulation
16%
Emerging Treatments
16%
Functional Connectivity
16%
Heart Rate Variability
16%
High-order
16%
Interaction Effect
33%
LF-HF Ratio
33%
Low-high Frequency
16%
Male Patients
100%
Modulation Response
33%
Multiple Domains
16%
Neuropathic Pain
16%
Pain Mechanisms
16%
Parasympathetic Tone
16%
Placebo
33%
Placebo-controlled
16%
Radicular
16%
Randomized Double-blind
16%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
16%
Rostral Ventrolateral Medulla
16%
Single Administration
16%
Sublingual Administration
16%
Supraspinal
100%
System Regulation
16%
T-10
16%
Tetrahydrocannabinol
100%
Top-down Effects
16%
Treatment Options
16%
Vagal Tone
16%
Variability Ratio
16%
Δ9-tetrahydrocannabinol (Δ9-THC)
100%
Medicine and Dentistry
Autonomic Nervous System
28%
Brain Region
14%
Chronic Pain
42%
Clinical Trial
14%
Dorsolateral Prefrontal Cortex
14%
Dronabinol
100%
Emerging Treatment
14%
Functional Connectivity
14%
Functional Magnetic Resonance Imaging
14%
Heart Rate Variability
14%
Neuropathic Pain
100%
Pain Modulation
100%
Parasympathetic Tone
100%
Placebo
100%
Rostral Ventrolateral Medulla
14%
Single Drug Dose
14%
Sublingual Administration
14%
Tetrahydrocannabinol
100%
Neuroscience
Autonomic Nervous System
25%
Dorsolateral Prefrontal Cortex
12%
Functional Connectivity
12%
Functional Magnetic Resonance Imaging
12%
Heart Rate Variability
12%
Medulla
12%
Neuropathic Pain
100%
Parasympathetic Tone
100%
Placebo
100%
Tetrahydrocannabinol
100%